State Department
Blinken visits Nigeria
State Department has not said whether LGBTQ rights specifically raised
The State Department has not said whether Secretary of State Antony Blinken specifically raised LGBTQ rights during his trip to Nigeria last week.
Blinken was in the country between Jan. 23-24. He also visited Cabo Verde, Cote d’Ivoire and Angola while in Africa.
A State Department spokesperson on Jan. 26 told the Washington Blade that Blinken while in Africa “had private conversations with public sector representatives engaged in the health field and with civil society representatives involved in human rights, democracy, education and food security work.”
A Jan. 24 post on Blinken’s X account includes a picture of him meeting with representatives of Nigerian civil society organizations. The post does not indicate whether any of those with whom Blinken met represent LGBTQ advocacy groups and/or identify as LGBTQ.
“Nigerian civil society organizations are critical to strengthening institutions and protecting human rights,” said Blinken. “I sat down with a few leaders to discuss the U.S.-Nigeria partnership to work on shared challenges and deliver on the fundamental aspirations of our peoples.”
Blinken also visited the Nigerian Institute of Medical Research in Lagos, the country’s largest city.
“The work that the U.S. and Nigeria are doing together goes back to the start of the HIV/AIDS epidemic and the extraordinary PEPFAR (President’s Emergency Plan for AIDS Relief) program,” said Blinken on a Jan. 24 X post. “I had the opportunity to tour the Nigerian Institute of Medical Research and see firsthand the work they are doing to improve public health.”
Blinken on Jan. 23 met with President Bola Tinubu in Abuja, the Nigerian capital, and later held a joint press conference with Foreign Affairs Minister Yusuf Tuggar.
“As I told the president and the foreign minister, the United States will support Nigeria as it works to bring about a more secure, a more peaceful and a more prosperous future for its people,” said Blinken.
“Fundamentally, this outcome is an investment in the foundations of an inclusive, democratic society — a focus on equal opportunity for all regardless of ethnicity, religion or any other group distinction,” he added. “That helps build the social cohesion. That also deters banditry, deters terrorism, deters violent extremism.”
Blinken during the press conference also highlighted PEPFAR and its work in Nigeria.
“Over the last 20 years, we’ve invested $8.3 billion in HIV and tuberculosis prevention, care, and treatment and in strengthening the public health system, reaching millions of Nigerians,” he said. “That effort will continue.”
President Joe Biden in 2021 signed a memo that commits the U.S. to the promotion of LGBTQ and intersex rights abroad as part of his administration’s overall foreign policy.
Vice President Kamala Harris last March spoke about LGBTQ rights during a press conference with Ghanaian President Nana Akufo-Addo in Accra, the country’s capital.
Ghana and Nigeria are among the countries in which consensual same-sex sexual relations remain criminalized. Homosexuality remains punishable by death in areas of Nigeria that are under Sharia law.
Then-Nigerian President Goodluck Jonathan in 2014 signed the Same-Sex Marriage Prohibition Act that, among other things, punishes those who enter into a same-sex marriage in his country with up to 14 years in prison and bans membership in an LGBTQ advocacy group.
Authorities in Gombe state last October arrested 76 people who were “celebrating homosexual birthdays” and planning to “hold a same-sex marriage.”
Police in Delta state last August took into custody more than 200 people who were attending a same-sex wedding at a hotel. Authorities later paraded some of those who were arrested in front of journalists.
“In our own programming and diplomatic engagements, we work with international partners in bilateral and multilateral forums to encourage strong and sustained support for democratic governance, respect for the human rights of all, labor rights, media freedom, a strong civil society and government transparency and accountability,” said the State Department spokesperson with whom the Blade spoke on Jan 26.
The spokesperson earlier in the week noted the promotion of “democracy, good governance and respect for human rights of all persons is at the center of our foreign policy, including in our relationships with our African partners.”
State Department
Report: US to withhold HIV aid to Zambia unless mineral access expanded
New York Times obtained Secretary of State Marco Rubio memo
The State Department is reportedly considering withholding assistance for Zambians with HIV unless the country’s government allows the U.S. to access more of its minerals.
The New York Times on Monday reported Secretary of State Marco Rubio in a memo to State Department’s Bureau of African Affairs staffers wrote the U.S. “will only secure our priorities by demonstrating willingness to publicly take support away from Zambia on a massive scale.” The newspaper said it obtained a copy of the letter.
Zambia is a country in southern Africa that borders Tanzania, Malawi, Mozambique, Zimbabwe, Botswana, Namibia, Angola, and the Democratic Republic of Congo.
The Times notes upwards of 1.3 million Zambians receive daily HIV medications through PEPFAR. The newspaper reported Rubio in his memo said the Trump-Vance administration could “significantly cut assistance” as soon as May.
“Reports of (the) State Department withholding lifesaving HIV treatment in return for mining concessions in Zambia does not make us safer, stronger, or more prosperous,” said U.S. Sen. Jeanne Shaheen (D-N.H.), the ranking member of the Senate Foreign Relations Committee, on Tuesday. “Monetizing innocent people’s lives further undermines U.S. global leadership and is just plain wrong.”
The Washington Blade has reached out to the State Department for comment.
Zambia received breakthrough HIV prevention drug through PEPFAR
Rubio on Jan. 28, 2025, issued a waiver that allowed PEPFAR and other “life-saving humanitarian assistance” programs to continue to operate during a freeze on nearly all U.S. foreign aid spending. HIV/AIDS service providers around the world with whom the Blade has spoken say PEPFAR cuts and the loss of funding from the U.S. Agency for International Development, which officially closed on July 1, 2025, has severely impacted their work.
The State Department last September announced PEPFAR will distribute lenacapavir in countries with high prevalence rates. Zambia two months later received the first doses of the breakthrough HIV prevention drug.
Kenya and Uganda are among the African countries have signed health agreements with the U.S. since the Trump-Vance administration took office.
The Times notes the countries that signed these agreements pledged to increase health spending. The Blade last month reported LGBTQ rights groups have questioned whether these agreements will lead to further exclusion and government-sanctioned discrimination based on sexual orientation and gender identity.
State Department
FOIA lawsuit filed against State Department for PEPFAR records
Council for Global Equality, Physicians for Human Rights seeking data, documents
The Council for Global Equality and Physicians for Human Rights have filed a Freedom of Information Act lawsuit against the State Department for PEPFAR-related data and documents.
The groups, which Democracy Forward represents, filed the lawsuit in U.S. District Court for the Southern District of New York on Wednesday.
Then-President George W. Bush in 2003 signed legislation that created PEPFAR. UNAIDS Executive Director Winnie Byanyima last March said PEPFAR has saved 26 million lives around the world.
The Trump-Vance administration in January 2025 froze nearly all U.S. foreign aid spending for at least 90 days. Secretary of State Marco Rubio later issued a waiver that allowed PEPFAR and other “life-saving humanitarian assistance” programs to continue to operate during the freeze.
The Washington Blade has previously reported PEPFAR-funded programs in Kenya and other African countries have been forced to suspend services and even shut down because of gaps in U.S. funding. HIV/AIDS activists have also sharply criticized the Trump-Vance administration over reported plans it will not fully fund PEPFAR in the current fiscal year.
The lawsuit notes the Council for Global Equality and Physicians for Human Rights have “filed several FOIA requests” with the State Department for PEPFAR-related data and documents. The groups filed their most recent request on Jan. 30.
“On Jan. 30, 2026, plaintiffs, through counsel, sent State a letter asking it to commit to prompt production of the requested records,” reads the lawsuit. “State responded that the request was being processed but did not commit to any timeline for production.”
“Plaintiffs have received no subsequent communication from State regarding this FOIA request,” it notes.
“Transparency and inclusion have been hallmarks of PEPFAR’s success in the last decade,” said Beirne Roose-Snyder, a senior policy fellow at the Council for Global Equality, in a press release that announced the lawsuit. “This unprecedented withholding of data, and concurrent ideological misdirection of foreign assistance to exclude LGBTQI+ people and others who need inclusive programming, has potentially devastating and asymmetrical impacts on already marginalized communities.”
“This data is vital to understanding who’s getting access to care and who’s being left behind,” added Roose-Snyder.
“We filed this lawsuit to seek transparency: the administration’s PEPFAR data blackout withholds information the public, health providers, and affected communities need to track the HIV epidemic and prevent avoidable illness and death, obscuring the true human cost of these policy decisions,” said Physicians for Human Rights Research, Legal, and Advocacy Director Payal Shah.
The State Department has yet to respond to the Blade’s request for comment on the lawsuit.
Eswatini
PEPFAR delivers first doses of groundbreaking HIV prevention drug to two African countries
Lenacapavir now available in Eswatini and Zambia.
The State Department on Tuesday announced PEPFAR has delivered the first doses of a groundbreaking HIV prevention drug to two African countries.
The lenacapavir doses arrived in Eswatini and Zambia.
The State Department in September unveiled an initiative with Gilead Sciences to bring lenacapavir “to market in high-burden HIV countries.”
Lenacapavir users inject the drug twice a year.
The State Department in its September announcement noted everyone who participated in Gilead’s clinical trials remained HIV negative. It also said lenacapavir “has the potential to be particularly helpful for pregnant and breastfeeding mothers, as it safely protects them during and after pregnancy to prevent mother-to-child transmission.”
“In our new America First Global Health Strategy, the Department of State is establishing a first-of-its-kind innovation fund to support American-led research, market-shaping, and other dynamic advancements in global health,” said PEPFAR on Tuesday in a press release.
“The arrivals of the first doses of lenacapavir in Eswatini and Zambia mark an important milestone in HIV prevention and reflect our commitment to supporting communities with the greatest need,” added Gilead CEO Daniel O’Day. “For the first time, a new HIV medicine is reaching communities in sub-Saharan Africa in the same year as its U.S. approval.”
The September announcement came against the backdrop of widespread criticism over the Trump-Vance administration’s reported plans to not fully fund PEPFAR and to cut domestic HIV/AIDS funding. The Washington Blade has previously reported PEPFAR-funded programs in Kenya and other African countries have been forced to curtail services or even close because of U.S. funding cuts.
Polish court rules country must recognize same-sex marriages from EU states
Capital Stonewall Democrats 50th anniversary gala draws ‘sold out’ crowd
PHOTOS: Capital Stonewall Democrats 50th anniversary
Small is beautiful: subcompact SUVs
‘Inherit the Wind’ isn’t about science vs. religion, but the right to think
SAVE Act could silence millions of trans voters
The frightening rise of antisemitism, Islamophobia
‘It’s Dorothy’ traces lasting influence of a cultural icon
Protesters say SAVE Act targets voters, transgender youth
